SYSTEMATIC REVIEW ON COST AND HEALTHCARE RESOURCE UTILIZATION IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

被引：0
|
作者：
Doherty, J. [1 ]
George, K. [2 ]
Akkapantula, S. [2 ]
Kolli, N. R. [2 ]
Pannagl, K. [3 ]
机构：
[1] Novartis Pharma AG, Basel, BS, Switzerland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[3] Novartis Pharmaceut UK Ltd, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE646
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [31] PATIENT INSIGHTS FOR IMMUNOGLOBULIN A NEPHROPATHY (IGAN) USING SOCIAL MEDIA LISTENING
    Tyagi, N.
    Aasaithambi, S.
    Chauhan, J.
    George, A.
    Zaour, N.
    VALUE IN HEALTH, 2019, 22 : S919 - S919
  • [32] Impact of poorly controlled hypertension on healthcare resource utilization and cost
    Paramore, LC
    Halpern, MT
    Lapuerta, P
    Hurley, JS
    Frost, FJ
    Fairchild, DG
    Bates, D
    AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (04): : 389 - 398
  • [33] Healthcare resource utilization and cost of care for Gaucher patients in Iran
    Davari, Majid
    Nabizadeh, Azita
    Kadivar, Maliheh
    Asl, Akbar Abdollahi
    Sarkheil, Peymaneh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2019, 18 (01) : 127 - 132
  • [34] Healthcare resource utilization and cost of care for Gaucher patients in Iran
    Majid Davari
    Azita Nabizadeh
    Maliheh Kadivar
    Akbar Abdollahi Asl
    Peymaneh Sarkheil
    Journal of Diabetes & Metabolic Disorders, 2019, 18 : 127 - 132
  • [35] Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
    Ramjee, Lauren
    Vurgun, Nesrin
    Ngai, Christopher
    Patel, Mit
    Tremblay, Gabriel
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 213 - 226
  • [36] ECONOMIC BURDEN AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH PSORIATIC ARTHRITIS (PsA): A SYSTEMATIC LITERATURE REVIEW
    Varga, S.
    Walia, S.
    Zema, C.
    Pushkarna, D.
    Dahan, S.
    Fazeli, M. S.
    Choi, J.
    Merola, J.
    VALUE IN HEALTH, 2024, 27 (06) : S90 - S90
  • [37] Anxiety disorders and healthcare utilization: A systematic review
    Horenstein, Arielle
    Heimberg, Richard G.
    CLINICAL PSYCHOLOGY REVIEW, 2020, 81
  • [38] Enhancing immunoglobulin A nephropathy management: insights from the IGAN-MIC project
    Jiang, Gengru
    Chen, Qinkai
    Zhang, Qinghong
    Tean, M. A.
    Chen, Chaosheng
    Bi, Guangyu
    Xing, Changying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2041 - I2042
  • [39] PROTEINURIA REDUCTION WITH SPARSENTAN IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN): PROTECT STUDY INTERIM RESULTS
    Radhakrishnan, Jai
    Wong, Muh Geot
    Heerspink, Hiddo J. L.
    Komers, Radko
    Prasad, Andy
    Mercer, Alex
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S97 - S97
  • [40] Ace gene polymorphism and disease progression in Malaysian patients with immunoglobulin a nephropathy (IgAN)
    Draman, Che Rosle
    Kong, Norella
    Rahman, Fauzi Abdul
    Radzi, Azizah Mohd
    Kuah, B. S.
    Azhar, Shamsul
    Phang, Koon-Seng
    Muhaizan, A. B. Wan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 68 - 68
12345